There was a statistically significant and clinically meaningful improvement in overall survival, progression free survival, and objective response rate compared to chemotherapy in the phase 3 KEYNOTE-775/Study 309 Trial.
The Combination Of Keytruda Plus Lenvima Improves Survival In Advanced Endometrial Cancer
Previous
Previous
CAPP2 Study Suggests People With Lynch Syndrome Should Take Aspirin To Reduce Colorectal Cancer Risk
Next
Next